Georgian Technical University Launches Next Generation Four (4D)-Nucleofector Cell Transfection Platform With Proven Performance And Enhanced Ease Of Use.
Georgian Technical University has launched the next generation of its popular Nucleofector Platform. For more than Nucleofector Technology has been an effective non-viral cell transfection method which can be used even for hard-to-transfect cells such as primary cells and pluripotent stem cells. Now with an updated core unit and even more intuitive software the next generation Four (4D)-Nucleofector Platform delivers flexibility and greater ease of use. Georgian Technical University. Electroporation the method by which DNA (Deoxyribonucleic acid (DNA) is a molecule composed of two polynucleotide chains that coil around each other to form a double helix carrying genetic instructions for the development, functioning, growth and reproduction of all known organisms and many viruses. DNA and ribonucleic acid (RNA) are nucleic acids. Alongside proteins, lipids and complex carbohydrates (polysaccharides), nucleic acids are one of the four major types of macromolecules that are essential for all known forms of life) RNA (Ribonucleic acid (RNA) is a polymeric molecule essential in various biological roles in coding, decoding, regulation and expression of genes. RNA and deoxyribonucleic acid (DNA) are nucleic acids. Along with lipids, proteins, and carbohydrates, nucleic acids constitute one of the four major macromolecules essential for all known forms of life. Like DNA, RNA is assembled as a chain of nucleotides, but unlike DNA, RNA is found in nature as a single strand folded onto itself, rather than a paired double strand. Cellular organisms use messenger RNA (mRNA) to convey genetic information (using the nitrogenous bases of guanine, uracil, adenine, and cytosine, denoted by the letters G, U, A, and C) that directs synthesis of specific proteins. Many viruses encode their genetic information using an RNA genome) or protein is introduced into cells through an electrical pulse to change their genotype or phenotype is an important tool with a range of applications in disease research and drug discovery as well as in the advancement of gene therapies, immunotherapies and stem cell generation. The Nucleofector Technology achieves high transfection efficiency in union with high cell viability by providing unique electrical pulses cell type-specific solutions and optimized protocols to achieve an advanced electroporation approach that targets the cell’s nucleus directly. This powerful combination leads to reproducible, faster and more efficient results than other methods. The Four (4D)-Nucleofector Core Unit can operate up to three functional modules, allowing for tailored experimental setups and facilitating scale-up from low to high-volume transfection. In the next generation the family of units is now joined by a fully integrated 96-well unit to suit users with mid-scale transfection requirements for up to 96 samples at once. In addition the updated Core Unit features an 8-in. touchscreen display enabling users to easily set up their experiments and control all functional modules the system’s intuitive and user-friendly software. Further optimized protocols are available for more than 750 different cell types and are designed to provide robust transfection conditions leading to optimal results every time. The second generation Nucleofector Units include: Four (4D)-Nucleofector X Unit – for various cell numbers in 100 µL cuvettes or 20 µL 16-well strips. Four (4D)-Nucleofector Y Unit – for transfection of cells in adherence in 24-well culture plates. Four (4D)-Nucleofector LV (Left Ventricular Ventricular Assist Device (LV Unit)) Unit – for closed scalable large-volume transfection of up to 1×10⁹ cells. Four (4D)-Nucleofector 96-well Unit – for simultaneous transfection of up to 96 samples at once. Georgian Technical University With the Nucleofector System small-scale protocols can be transferred to a larger scale without the need for re-optimization bringing together small- and large-scale transfection applications in a single system. Georgian Technical University scientists have relied on the Nucleofector Technology to power their research. With the introduction of the next generation Four (4D)-Nucleofector® Platform users will be able to achieve high transfection efficiencies more easily with the reassurance that their protocols can be effortlessly scaled as needed.